Keyphrases
Biomaterials
100%
Cancer Treatment
100%
In Cancer
100%
Immune Cells
100%
Targeted Modulation
100%
Cancer Immunotherapy
66%
Synergistic Effect
33%
T Cells
33%
Clinical Utility
33%
B Cells
33%
Patient Response
33%
Dendritic Cells
33%
Natural Killer Cells
33%
Cell Tumor
33%
Life-threatening
33%
High Cost
33%
Longest Processing Time
33%
Clinical Efficacy
33%
Response Cost
33%
Troubleshooting
33%
Immunomodulation
33%
Myeloid-derived Suppressor Cells
33%
Tumor-associated Macrophages
33%
Immunomodulatory Effect
33%
Chimeric Antigen Receptor T-cell Therapy
33%
Immune Checkpoint Therapy
33%
Medicine and Dentistry
Biocompatible Material
100%
Cancer Therapy
100%
Immunocompetent Cell
100%
Neoplasm
33%
Malignant Neoplasm
33%
Macrophage
33%
Health Care Cost
33%
B Cell
33%
T Cell
33%
Side Effect
33%
Dendritic Cell
33%
Immunotherapy
33%
Natural Killer Cell
33%
Immunomodulation
33%
Cancer Immunotherapy
33%
Chimeric Antigen Receptor T-Cell Immunotherapy
33%
Myeloid-Derived Suppressor Cell
33%
Immune Checkpoint Blockade
33%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Biomaterial
100%
Immunotherapy
40%
Side Effect
20%
Neoplasm
20%
Chimeric Antigen Receptor
20%
Immunomodulation
20%
Material Science
Biomaterial
100%
T-Cells
100%
Tumor
50%
Macrophage
50%